Asclemed USA Inc. dba Enovachem Pharmaceuticals recalls
FDA enforcement reports naming Asclemed USA Inc. dba Enovachem Pharmaceuticals as the recalling firm.
- Recall reports
- 4
- Class I (serious)
- 0
- Most recent report
- Apr 21, 2021
- Apr 21, 2021Distributed by: DocRx, Methylprednisolone Tablets, USP 4 mg, Rx, 21 Count BlisterDrug · Asclemed USA Inc. dba Enovachem PharmaceuticalsLabeling: Illegible label: Manufacturer received complaint of mis-alignment print of the printed dosing instructions on the blister card.Class III
- Jan 15, 2020Estriol, USP, (Micronized), 0Drug · Asclemed USA Inc. dba Enovachem PharmaceuticalsFailed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.Class II
- Jan 15, 2020Estriol, USP, (Micronized), 0Drug · Asclemed USA Inc. dba Enovachem PharmaceuticalsFailed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.Class II
- Jan 15, 2020Estriol, USP, (Micronized), 0Drug · Asclemed USA Inc. dba Enovachem PharmaceuticalsFailed Impurities/Degradation Specifications: Additional testing found Out of Specification impurity test results.Class II